OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,650 | -57.9% | 22,500 | -30.8% | 0.01% | -57.9% |
| Q2 2023 | $167,700 | -84.7% | 32,500 | -84.3% | 0.02% | -86.0% |
| Q1 2023 | $1,094,178 | +43.8% | 207,624 | -23.3% | 0.14% | +33.3% |
| Q4 2022 | $760,645 | -49.6% | 270,692 | -25.6% | 0.10% | -50.2% |
| Q3 2022 | $1,510,000 | +183.3% | 363,844 | +174.3% | 0.20% | +225.4% |
| Q2 2022 | $533,000 | -13.2% | 132,654 | +80.0% | 0.06% | -25.0% |
| Q2 2020 | $614,000 | +314.9% | 73,678 | +145.6% | 0.08% | +250.0% |
| Q1 2020 | $148,000 | -16.9% | 30,000 | -33.3% | 0.02% | +33.3% |
| Q4 2019 | $178,000 | – | 45,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |